Who responds best to CagriSema Ideal candidates: Significant obesity (BMI 30-40+) Previously plateaued on GLP-1s alone Need maximum weight loss Good GI tolerability Metabolic syndrome or diabetes Commitment to long-term use Excellent responders: Higher baseline weight (more to lose) Good adherence to protocol Combine with diet/exercise Younger patients (better metabolism) No significant medication interactions May respond less optimally: Very low starting weight (BMI 30%): Nausea (most common) Decreased appetite (intended effect) Constipation Fatigue (especially first months) Common (10-30%): Vomiting (if nausea not managed) Diarrhea (alternating with constipation) Abdominal pain/discomfort Headache Dizziness Less common ( 40 with comorbidities Insurance covers surgery Want permanent solution Don't want ongoing injections Sourcing cagrilintide and semaglutide Obtaining these peptides requires understanding current availability
![liposomal glutathione film [Standard Pack] Direct 30 Strips esther glutathione film Lyuh Esther](https://cdn.shopify.com/s/files/1/0906/2003/5459/files/f_015a0527-3dd0-4b73-a84b-121c0fb6da93.jpg?v=1754482919)
Many people focus on diet, exercise, and medications to support their cardiovascular system
But you can't practise evidence-based medicine on a substance that has no evidence," said Phillips
10.1183/09031936.00001010 106 Lachowicz-ScrogginsM
Cappello M., Barbara G., Bellini M., et al., Identification and Management of Gastrointestinal Manifestations of Hereditary Transthyretin Amyloidosis: Recommendations From an Italian Group of Experts, Digestive and Liver Disease 56, no